Bank Julius Baer & Co. Ltd, Zurich Cidara Therapeutics, Inc. Transaction History

Bank Julius Baer & Co. Ltd, Zurich

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$1.99 - $3.25 $25,870 - $42,250	-13,000 Closed	0 $0
Q2 2020 Aug 12, 2020	BUY	$2.39 - $4.0 $16,412 - $27,468	6,867 Added 111.97%	13,000 $48,000
Q1 2020 May 13, 2020	BUY	$1.74 - $4.26 $10,671 - $26,126	6,133 New	6,133 $15,000

Ticker CDTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,075,696
Market Cap $1.63B
Description
Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifu...

Get notified when there are updates to the investment portfolio of Bank Julius Baer & Co. Ltd, Zurich, based on Form 13F filings with the SEC.

Stay updated on Bank Julius Baer & Co. Ltd, Zurich with notifications on news.